Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC...

19
Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC investigators Iris van Hagen Titia Ruijs Waltraut Merz Sorel Goland Harald Gabriel Malgorzata Lelonek Olga Trojnarska Wael Al Mahmeed Hajnalka Balint Zeinab Ashour Helmut Baumgartner Eric Boersma EURObservational Research Programme

Transcript of Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC...

Page 1: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Pregnancy in Women with Prosthetic Heart Valves

Registry Of Pregnancy And Cardiac disease: ROPAC

Jolien Roos-HesselinkRoger Hall

On behalf of the ROPAC investigators

Iris van HagenTitia Ruijs

Waltraut MerzSorel Goland

Harald GabrielMalgorzata Lelonek

Olga Trojnarska

Wael Al MahmeedHajnalka BalintZeinab Ashour

Helmut BaumgartnerEric Boersma

EURObservational Research Programme

Page 2: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

I have nothing to disclose.

EURObservational Research Programme

Page 4: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Methods

• ROPAC Registry Of Pregnancy And Cardiac disease

• ESC: EURObservational Research Programme (EORP)

• 2007 – 2014

• Ongoing worldwide Registry

• Online CRF

• Prospective

EURObservational Research Programme

Page 5: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

48 countries, 132 centers, 2966 pregnancies

EURObservational Research Programme

Page 6: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Baseline

EURObservational Research Programme

Page 7: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Baseline

EURObservational Research Programme

Mechanical valve

CHDVHDAortic disease

Tissue valve

CHD*VHD*Aortic disease

No prosthetic valve

CHD*VHD*IHD*CMP*Aortic disease*PAH

* p<0.05 vs mechanical valve

Page 8: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Baseline

EURObservational Research Programme

Mechanical212

Tissue134

No prosthesis2620

AF % 10 0* 2*

NYHA class I % 74 77 73

Signs of CHF % 15 4* 7*

* p<0.05 vs mechanical valve

Page 9: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Complications

EURObservational Research Programme

Mechanical valve212

Cardiac patients No prosthesis

2620

Maternal mortality1.4% 0.2%*

Thrombotic event6.1% 0.4%*

Haemorrhagic event23% 5%*

Miscarriage <24 wks15.6% 1.7%*

Fetal mortal >24 wks2.8% 0.6%*

* p<0.05

Page 10: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Mode of delivery

Performed Mechanical212

No prosthesis2620

Vaginal 54% 52%

Caesarean Section 46% 48%

Emergency CS 9% 15%

EURObservational Research Programme

Planned Mechanical212

No prosthesis2620

Vaginal 61% 64%

Caesarean Section 39% 36%

Page 11: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Live births

Mechanical valve Tissue valve No prosthetic valve0

10

20

30

40

50

60

70

80

90

100

%

p<0.001

p=0.571

EURObservational Research Programme

Page 12: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Mechanical valve thrombosis

Incidence: 10 patients (4.7%)

EURObservational Research Programme

Total VKA Heparin

1st trimester 5 0 5

2nd trimester 2 1 1

3rd trimester 3 3 0

Page 13: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Anticoagulation

EURObservational Research Programme

Page 14: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Regimes

<14 wks 14-36 wks 36 wks - delivery n %

1 VKA VKA VKA 6 3

2 VKA VKA LMWH/UH 37 20

3 LMWH LMWH LMWH 18 10

4 UH UH UH 21 11

5 LMWH VKA LMWH/UH 32 17

6 UH VKA LMWH/UH 48 25

7 Other regimes 24 12

VKA= Vitamin K antagonistsUH = Unfractionated HeparinLMWH = Low Molecular Weight Heparin

Page 15: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Results Regimes

Hemorrhagic events

Thrombotic events

Live Birth0

20

40

60

80

100

120

VKA-VKA-VKAVKA-VKA-LMWH/UHLMWH-LMWH-LMWHUH-UH-UHLMWH-VKA-LMWH/UHUH-VKA-LMWH/UHOther regimes

p = 0.272

p = 0.366

p = 0.013

Page 16: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Discussion

• Choice of valve type in a young woman

• Interregional differences

• Guidelines for anticoagulation

• The (in)feasibility of an RCT

EURObservational Research Programme

Page 17: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Conclusion

• Pregnant women with a mechanical valve prosthesis are at high risk: Event-free pregnancy resulting in a live birth was 58% versus 78% in other cardiac patients.

• There is a wide variety in used regimes for anticoagulation

• Vitamin k antagonists seem associated with high offspring mortality (miscarriages)

• Heparin in the first trimester was associated with valve thrombosis

• Not one regime turned out to be clearly optimal

EURObservational Research Programme

Page 18: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Clinical implications

• Pre-pregnancy counseling performed by an experienced specialist is mandatory explaining the different treatment options and their complication rates.

• After providing extensive information, a shared-decision should be searched for towards the best regime for the individual patient.

• All patients with a mechanical valve are at high risk during pregnancy and therefore the care for these patients should be concentrated in a few specialized centers

Speaker

Page 19: Pregnancy in Women with Prosthetic Heart Valves Registry Of Pregnancy And Cardiac disease: ROPAC Jolien Roos-Hesselink Roger Hall On behalf of the ROPAC.

Acknowledgements: EORP Team and ROPAC investigators

EURObservational Research Programme

Please join [email protected]